Leaflet DUODOPA 20mg / 5mg / ml intestinal gel

Product code:
W60962001
Quantity:
7
Indicated for:
Parkinson's disease
Route of administration:
intestinal
Substance:
levodopa + carbidopa (antiparkinsonian agents)
ATC
N04BA02 — Nervous system | Dopaminergic agents | Dopa and dopa derivatives

Precautions:

Driving impairment

Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo

Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Hypotension / fall risk

Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Drowsiness / sedation

Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Levodopa + Carbidopa is a combination medication used in the treatment of Parkinson's disease and parkinsonian syndromes. Levodopa is a precursor of dopamine, which helps compensate for the dopamine deficiency in the brain characteristic of these conditions. Carbidopa is a peripheral decarboxylase inhibitor that prevents levodopa from being converted into dopamine outside the brain, increasing the amount of levodopa that reaches the brain and reducing side effects such as nausea.

This combination is effective in alleviating symptoms such as tremors, muscle rigidity, bradykinesia (slowness of movement), and balance difficulties. The medication is usually administered in gradually adjusted doses to minimize side effects and optimize benefits.

Side effects may include nausea, dizziness, drowsiness, motor fluctuations (such as 'on-off' phenomena), or, in rare cases, hallucinations and mood changes. It is important to take the medication as prescribed by a doctor, with regular monitoring to adjust doses based on the progression of the disease.

General data about DUODOPA 20mg / 5mg / ml

Substance:
levodopa + carbidopa
Date of latest medicines list:
01-06-2026
Product code:
W60962001
Concentration:
20mg / 5mg / ml
Pharmaceutical form:
intestinal gel
Quantity:
7
Product type:
Original
Price:
2993.80 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
FRESENIUS KABI NORGE AS - NORVEGIA
Holder:
ABBVIE DEUTSCHLAND GMBH & CO. KG - GERMANIA
Number:
12111/2019/01
Shelf life:
15 weeks-after packing for marketing;after opening-it is used immediately

Pharmaceutical forms available for levodopa + carbidopa

Concentrations available for levodopa + carbidopa

  • 100mg/25mg
  • 2000mg/500mg
  • 200mg/50mg
  • 20mg/5mg/ml
  • 250mg/25mg

Combinations with other substances

Compensation lists for DUODOPA 20mg / 5mg / ml AbbVie

G12 (C1) - Parkinson's disease

Price
2993.80 RON
Copayment
2993.80 RON
Patient
0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price
2993.80 RON
Copayment
2993.80 RON
Patient
0.00 RON